Los hitos relevantes para investigacin son: Coskun et al., 2022 (Cell Metabolism): caracterizacin molecular del compuesto LY3437943, demostrando potencia comparable al GLP-1 endgeno sobre GLP-1R y actividad sustancial sobre GIP-R y GCG-R, con balance racionalmente diseado
The State Health Plan Board of Trustees concluded that coverage of these drugs for weight loss purposes was no longer financially feasible and would have required a premium increase of $48.50 per member per month
Improved blood sugar and insulin sensitivity For Ginger Vieira, author of the book Exercise with Type 1 Diabetes, several changes in her mid-30s led her to consider taking diabetes medications off-label
It's not as impulsive or reactive as it was before
A phase 2 randomized, placebo-controlled interventional trial explored weight loss in patients with obesity or overweight with at least one weight-related coexisting condition was recently completed
The drug received FDA approval for the treatment of obstructive sleep apnea in 2024